BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8674839)

  • 1. Estradiol and triiodothyronine increase production of insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) by GH4C1 rat pituitary tumor cells.
    Gilchrist CA; Park JH; MacDonald RG; Shull JD
    Mol Cell Endocrinol; 1995 Oct; 114(1-2):147-56. PubMed ID: 8674839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation.
    Zhou-Li F; Albaladejo V; Joly-Pharaboz MO; Nicolas B; Andre J
    Endocrinology; 1992 Mar; 130(3):1145-52. PubMed ID: 1537281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of insulin-like growth factors and their binding proteins in the estrogen responsive Ishikawa human endometrial cancer cell line.
    Hana V; Murphy LJ
    Endocrinology; 1994 Dec; 135(6):2511-6. PubMed ID: 7527333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multihormonal control of cell proliferation: opposite effects of two stimulators (17 beta-estradiol and L-triiodothyronine) and one inhibitor (dexamethasone) on F4Z2 pituitary tumor cells.
    Zhou-Li F; Joly-Pharaboz MO; Bouillard B; Albaladejo V; Nicolas B; Andre J
    Endocrinology; 1991 Jun; 128(6):2761-8. PubMed ID: 2036960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The estrogen-occupied estrogen receptor functions as a negative regulator to inhibit cell proliferation induced by insulin/IGF-1: a cell context-specific antimitogenic action of estradiol on rat lactotrophs in culture.
    Kawashima K; Yamakawa K; Takahashi W; Takizawa S; Yin P; Sugiyama N; Kanba S; Arita J
    Endocrinology; 2002 Jul; 143(7):2750-8. PubMed ID: 12072410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of insulin-like growth factor binding protein expression by ICI 182,780 in a tamoxifen-resistant human breast cancer cell line.
    Parisot JP; Leeding KS; Hu XF; DeLuise M; Zalcberg JR; Bach LA
    Breast Cancer Res Treat; 1999 Jun; 55(3):231-42. PubMed ID: 10517168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
    Chan TW; Pollak M; Huynh H
    Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factors (IGF-I and IGF-II) and IGF-binding protein-3 production by fibroblasts of patients with Turner's syndrome in culture.
    Barreca A; Larizza D; Damonte G; Arvigo M; Ponzani P; Cesarone A; Lo Curto F; Severi F; Giordano G; Minuto F
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1041-6. PubMed ID: 9100570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The estrogenic and antiestrogenic properties of tamoxifen in GH4C1 pituitary tumor cells are gene specific.
    Shull JD; Beams FE; Baldwin TM; Gilchrist CA; Hrbek MJ
    Mol Endocrinol; 1992 Apr; 6(4):529-35. PubMed ID: 1584221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.
    Lee AV; Weng CN; Jackson JG; Yee D
    J Endocrinol; 1997 Jan; 152(1):39-47. PubMed ID: 9014838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of pituitary-specific gene expression by insulin-like growth factor 1 in rat pituitary GH4C1 and GH3 cells.
    Castillo AI; Aranda A
    Endocrinology; 1997 Dec; 138(12):5442-51. PubMed ID: 9389530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independence of estrogen-induced pituitary proliferation on local IGF-I mRNA and EGF mRNA expression. Modifying effects of tamoxifen and terguride.
    Hána V; Haluzík M; Schreiber V
    Physiol Res; 1998; 47(2):125-31. PubMed ID: 9706996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triiodothyronine (T3) stimulates insulin-like growth factor (IGF)-1 and IGF binding protein (IGFBP)-2 production by rat osteoblasts in vitro.
    Schmid C; Schläpfer I; Futo E; Waldvogel M; Schwander J; Zapf J; Froesch ER
    Acta Endocrinol (Copenh); 1992 May; 126(5):467-73. PubMed ID: 1377854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486).
    Milewicz T; Gregoraszczuk EL; Sztefko K; Augustowska K; Krzysiek J; Ryś J
    Growth Horm IGF Res; 2005 Apr; 15(2):140-7. PubMed ID: 15809018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of circulating insulin-like growth factor I (IGF-I) and insulin-like growth factor binding proteins (IGFBP) due to administration of a combined trenbolone acetate and estradiol implant in feedlot cattle.
    Johnson BJ; Hathaway MR; Anderson PT; Meiske JC; Dayton WR
    J Anim Sci; 1996 Feb; 74(2):372-9. PubMed ID: 8690673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I (IGF-I) regulates IGFBP-3 and IGFBP-4 by multiple mechanisms in A549 human adenocarcinoma cells.
    Price WA; Moats-Staats BM; Stiles AD
    Am J Respir Cell Mol Biol; 1995 Oct; 13(4):466-76. PubMed ID: 7546777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol increases relative amounts of insulin-like growth factor binding protein (IGFBP)-3 in serum and expression of IGFBP-2 in anterior pituitaries of ewes.
    Clapper JA; Snyder JL; Roberts AJ; Hamernik DL; Moss GE
    Biol Reprod; 1998 Jul; 59(1):124-30. PubMed ID: 9675002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population density alters the responsiveness of GH4C1 pituitary tumor cells to 17 beta-estradiol.
    Shull JD
    Endocrinology; 1991 Sep; 129(3):1644-52. PubMed ID: 1874194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary insulin-like growth factor-I gene expression: regulation by triiodothyronine and growth hormone.
    Fagin JA; Fernandez-Mejia C; Melmed S
    Endocrinology; 1989 Nov; 125(5):2385-91. PubMed ID: 2791994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential mechanism of estrogen-mediated decrease in bone formation: estrogen increases production of inhibitory insulin-like growth factor-binding protein-4.
    Kassem M; Okazaki R; De León D; Harris SA; Robinson JA; Spelsberg TC; Conover CA; Riggs BL
    Proc Assoc Am Physicians; 1996 Mar; 108(2):155-64. PubMed ID: 8705735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.